Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ASK: "THE LAST DON" OF MOMENTUM TRADES -- Ignore unavailable to you. Want to Upgrade?

To: Michael E. Baldino who wrote (5548)	2/4/1999 2:32:00 PM
From: myturn	Read Replies (2) \| Respond to of 15987

ADGI, news is out! ADGI Delivers Pharmaceuticals Under New Malian Orders BusinessWire, Thursday, February 04, 1999 at 14:24 HICKORY, N.C.--(BUSINESS WIRE)--Feb. 4, 1999--American Diversified Group (OTC BB:ADGI) Thursday announced that it has delivered new generic pharmaceutical products to the Republic of Mali under continuing purchase orders. ADGI previously announced on Jan. 11, 1999 that it has been requested to source and supply up to 300 generic pharmaceutical products for sale to the Republic of Mali during fiscal 1999, which request was received through its new West African representatives. The shipment by Ethiopian Air, arrived in Mali on Feb. 3, 1999, included Paracetamol (500,000 units), Aluminum Hydroxide (500,000 units), Chloroquine (600,000 units) and Multivitamins (300,000 units). The products have been sourced from Quali-Care, an Indian manufacturer, under an exclusive agreement with ADGI for West Africa. ADGI is presently sourcing 30 additional products for its existing Malian orders, which products include a range of antibiotics, anti-inflammatories, anti-viral drugs for malaria among other diseases, and multivitamins. ADGI projects the sale and schedule for delivery of these products during the next 30-45 day period. ADGI projects continued and regular orders and the sale of pharmaceutical products during the remainder of 1999. ADGI's President, Jerrold R. Hinton, stated, "The company is pleased with its new West African representatives, who have complimented ADGI's development strategies for the growth of its West African business." For further information, please contact ADGI's Executive Offices at 110 N. Center St., Suite 202, Hickory, NC 28601 - Tel: 828/322-2044 - Fax 828/322-3798. ADGI also maintains its NY Investor Relations office at 45 Rockefeller Plaza, 20th FL, NY, NY 10111 - Tel: 212/332-5009 - Fax 212/332-3249. Except for the historical information herein, the matters discussed in this press release includes forward-looking statements that may involve a number of risks and uncertainties. Actual results may vary based upon a number of factors, including, but not limited to, risks in product and technology development, market acceptance of new products and continuing demand, the impact of competitive products and pricing, changing economic conditions and other risk factors contained in the company's most recent annual report and other filings with the Securities and Exchange Commission. CONTACT: American Diversified Group, Hickory Jerrold Hinton, Ph.D., 828/322-2044 828/322-3798 (fax) KEYWORD: NORTH CAROLINA INDUSTRY KEYWORD: PHARMACEUTICALS Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com